Published in Genome Res on January 01, 2001
VISTA: computational tools for comparative genomics. Nucleic Acids Res (2004) 13.52
Exogenous α-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron (2011) 4.74
Parallel construction of orthologous sequence-ready clone contig maps in multiple species. Genome Res (2002) 2.18
GATA transcription factors directly regulate the Parkinson's disease-linked gene alpha-synuclein. Proc Natl Acad Sci U S A (2008) 2.17
Generation and comparative analysis of approximately 3.3 Mb of mouse genomic sequence orthologous to the region of human chromosome 7q11.23 implicated in Williams syndrome. Genome Res (2002) 1.80
Deletion of the alpha-synuclein locus in a subpopulation of C57BL/6J inbred mice. BMC Neurosci (2001) 1.77
α-Synuclein and dopamine at the crossroads of Parkinson's disease. Trends Neurosci (2010) 1.49
Functional analysis of intra-allelic variation at NACP-Rep1 in the alpha-synuclein gene. Hum Genet (2003) 1.38
Extensive enteric nervous system abnormalities in mice transgenic for artificial chromosomes containing Parkinson disease-associated alpha-synuclein gene mutations precede central nervous system changes. Hum Mol Genet (2010) 1.36
Genetic regulation of alpha-synuclein mRNA expression in various human brain tissues. PLoS One (2009) 1.34
Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse. Genome Res (2003) 1.32
Regulation of alpha-synuclein expression by poly (ADP ribose) polymerase-1 (PARP-1) binding to the NACP-Rep1 polymorphic site upstream of the SNCA gene. Am J Hum Genet (2005) 1.30
Expansion of the Parkinson disease-associated SNCA-Rep1 allele upregulates human alpha-synuclein in transgenic mouse brain. Hum Mol Genet (2009) 1.21
alpha-Synuclein maps to a quantitative trait locus for alcohol preference and is differentially expressed in alcohol-preferring and -nonpreferring rats. Proc Natl Acad Sci U S A (2003) 1.18
Chasing genes in Alzheimer's and Parkinson's disease. Hum Genet (2004) 1.11
Full sequence and comparative analysis of the plasmid pAPEC-1 of avian pathogenic E. coli chi7122 (O78:K80:H9). PLoS One (2009) 1.07
ER stress response plays an important role in aggregation of α-synuclein. Mol Neurodegener (2010) 0.99
Regulation of alpha-synuclein expression in alcohol-preferring and -non preferring rats. J Neurochem (2006) 0.87
Up-regulation of SNCA gene expression: implications to synucleinopathies. Neurogenetics (2016) 0.80
Reduced expression of α-synuclein in alcoholic brain: influence of SNCA-Rep1 genotype. Addict Biol (2012) 0.80
Strong conservation of the human NF2 locus based on sequence comparison in five species. Mamm Genome (2003) 0.77
Discovery of functional non-coding conserved regions in the α-synuclein gene locus. F1000Res (2014) 0.77
Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug Screening. PLoS One (2015) 0.77
Region-specific deficits in dopamine, but not norepinephrine, signaling in a novel A30P α-synuclein BAC transgenic mouse. Neurobiol Dis (2013) 0.77
Transgenic mice expressing S129 phosphorylation mutations in α-synuclein. Neurosci Lett (2014) 0.76
Screening of Transcription Factors Involved in Fetal Hemoglobin Regulation Using Phylogenetic Footprinting. Evol Bioinform Online (2015) 0.75
Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review. Front Mol Neurosci (2016) 0.75
Structural variants in SNCA gene and the implication to synucleinopathies. Curr Opin Genet Dev (2017) 0.75
Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA. Prog Neurobiol (2017) 0.75
Basic local alignment search tool. J Mol Biol (1990) 659.07
Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res (1998) 106.16
Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res (1998) 96.63
Consed: a graphical tool for sequence finishing. Genome Res (1998) 59.36
Prediction of complete gene structures in human genomic DNA. J Mol Biol (1997) 58.76
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30
MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res (1995) 21.22
Alpha-synuclein in Lewy bodies. Nature (1997) 20.83
PipMaker--a web server for aligning two genomic DNA sequences. Genome Res (2000) 17.46
Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat Genet (1998) 12.92
VISTA : visualizing global DNA sequence alignments of arbitrary length. Bioinformatics (2000) 12.50
Long human-mouse sequence alignments reveal novel regulatory elements: a reason to sequence the mouse genome. Genome Res (1997) 8.49
Human and mouse gene structure: comparative analysis and application to exon prediction. Genome Res (2000) 8.28
Active conservation of noncoding sequences revealed by three-way species comparisons. Genome Res (2000) 6.18
Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. Mamm Genome (1994) 5.38
Large-scale comparative sequence analysis of the human and murine Bruton's tyrosine kinase loci reveals conserved regulatory domains. Genome Res (1997) 4.82
Comparative analysis of 1196 orthologous mouse and human full-length mRNA and protein sequences. Genome Res (1996) 4.11
PowerBLAST: a new network BLAST application for interactive or automated sequence analysis and annotation. Genome Res (1997) 4.10
Analysis of vertebrate SCL loci identifies conserved enhancers. Nat Biotechnol (2000) 4.01
Striking sequence similarity over almost 100 kilobases of human and mouse T-cell receptor DNA. Nat Genet (1994) 3.88
Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science (1996) 3.79
Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. Proc Natl Acad Sci U S A (1993) 3.73
The human genome: organization and evolutionary history. Annu Rev Genet (1995) 3.11
Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype. Ann Neurol (1999) 1.74
The synuclein family. Genome Res (1998) 1.65
Alpha-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the parkinsonian toxin MPTP. J Neurochem (2000) 1.49
The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion. Genome Res (2000) 1.32
Comparative genomic sequencing identifies novel tissue-specific enhancers and sequence elements for methylation-sensitive factors implicated in Igf2/H19 imprinting. Genome Res (2000) 1.30
Comparative genomic sequence analysis of the human and mouse cystic fibrosis transmembrane conductance regulator genes. Proc Natl Acad Sci U S A (2000) 1.19
Comparative genome sequence analysis of the Bpa/Str region in mouse and Man. Genome Res (2000) 1.13
Increased expression of rat synuclein in the substantia nigra pars compacta identified by mRNA differential display in a model of developmental target injury. J Neurochem (1999) 0.99
So many genomes, so little time. Nat Biotechnol (2000) 0.97
Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism. Ann Neurol (1996) 0.96
The human NACP/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis. Genomics (1995) 0.96
The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease. Genomics (1995) 0.94
Rapid isolation of DNA sequences flanking microsatellite repeats. Nucleic Acids Res (1994) 0.88
Genomic sequence analysis of Fugu rubripes CFTR and flanking genes in a 60 kb region conserving synteny with 800 kb of human chromosome 7. Genome Res (2000) 0.80
Failure to replicate a protective effect of allele 2 of NACP/alpha-synuclein polymorphism in Alzheimer's disease: an association study. Ann Neurol (1998) 0.79
Dinucleotide repeat polymorphism at the D7S476 locus. Hum Mol Genet (1992) 0.78
Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science (1997) 28.30
Complementary DNA sequencing: expressed sequence tags and human genome project. Science (1991) 19.42
A gene map of the human genome. Science (1996) 14.32
VISTA : visualizing global DNA sequence alignments of arbitrary length. Bioinformatics (2000) 12.50
A physical map of 30,000 human genes. Science (1998) 12.43
Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science (1997) 6.66
The ubiquitin pathway in Parkinson's disease. Nature (1998) 4.48
The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell (1993) 4.10
Mutations in a new gene in Ellis-van Creveld syndrome and Weyers acrodental dysostosis. Nat Genet (2000) 3.87
Mapping of a gene for Parkinson's disease to chromosome 4q21-q23. Science (1996) 3.79
Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet (1989) 3.37
Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase. J Biol Chem (1999) 3.17
Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome. Cell (1994) 3.01
DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology (2007) 2.86
Organization of the HPRT gene and related sequences in the human genome. Somat Cell Mol Genet (1984) 2.84
A three-allele restriction-fragment-length polymorphism at the hypoxanthine phosphoribosyltransferase locus in man. Proc Natl Acad Sci U S A (1983) 2.73
The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase. Nature (1992) 2.64
Mouse major histocompatibility class I gene expression begins at midsomite stage and is inducible in earlier-stage embryos by interferon. Proc Natl Acad Sci U S A (1985) 2.56
Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system. Hum Mol Genet (2001) 2.52
Assessing adequacy of collateral circulation during balloon test occlusion of the internal carotid artery with 99mTc-HMPAO SPECT. AJNR Am J Neuroradiol (1992) 2.30
Parkinsonism among Gaucher disease carriers. J Med Genet (2004) 2.24
Cloning of human and bovine homologs of SNF2/SWI2: a global activator of transcription in yeast S. cerevisiae. Nucleic Acids Res (1992) 2.14
Alpha synuclein is present in Lewy bodies in sporadic Parkinson's disease. Mol Psychiatry (1998) 2.12
The fragile X mental retardation syndrome protein interacts with novel homologs FXR1 and FXR2. EMBO J (1995) 2.05
Single pass sequencing and physical and genetic mapping of human brain cDNAs. Nat Genet (1992) 2.01
Addressing the challenges of the clinical application of pharmacogenetic testing. Clin Pharmacol Ther (2009) 1.99
A rodent-human hybrid containing Xq24-qter translocated to a hamster chromosome expresses the Xq27 folate-sensitive fragile site. Am J Med Genet (1986) 1.94
Mutations in American families with spinocerebellar ataxia (SCA) type 3: SCA3 is allelic to Machado-Joseph disease. Neurology (1996) 1.87
Sequence and analysis of chromosome 1 of the plant Arabidopsis thaliana. Nature (2000) 1.85
Isolation of anonymous DNA sequences from within a submicroscopic X chromosomal deletion in a patient with choroideremia, deafness, and mental retardation. Proc Natl Acad Sci U S A (1987) 1.83
Mapping of human chromosome 5 microsatellite DNA polymorphisms. Genomics (1991) 1.74
Pathogenesis of adenocarcinoma in Peutz-Jeghers syndrome. Cancer Res (1998) 1.73
Human chromosomal assignments for 14 argininosuccinate synthetase pseudogenes: cloned DNAs as reagents for cytogenetic analysis. Am J Hum Genet (1984) 1.73
Carrier detection in X-linked severe combined immunodeficiency based on patterns of X chromosome inactivation. J Clin Invest (1987) 1.67
Fragile X syndrome: a unique mutation in man. Annu Rev Genet (1986) 1.66
Two anonymous X-specific human sequences detecting restriction fragment length polymorphisms in region Xq26----qter. Somat Cell Mol Genet (1984) 1.65
The oculocerebrorenal syndrome gene product is a 105-kD protein localized to the Golgi complex. Am J Hum Genet (1995) 1.64
Nonsense mutations in the OCRL-1 gene in patients with the oculocerebrorenal syndrome of Lowe. Hum Mol Genet (1993) 1.63
Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5). J Biol Chem (1994) 1.62
Heterogeneity of clinical severity and molecular lesions in Aicardi syndrome. J Pediatr (1990) 1.62
FXR1, an autosomal homolog of the fragile X mental retardation gene. EMBO J (1995) 1.61
Functional overlap between murine Inpp5b and Ocrl1 may explain why deficiency of the murine ortholog for OCRL1 does not cause Lowe syndrome in mice. J Clin Invest (1998) 1.59
Expression of the fragile (X) chromosome in an interspecific somatic cell hybrid. Hum Genet (1983) 1.55
Mapping a gene involved in regulating dietary cholesterol absorption. The sitosterolemia locus is found at chromosome 2p21. J Clin Invest (1998) 1.55
Targeted disruption of the Cln3 gene provides a mouse model for Batten disease. The Batten Mouse Model Consortium [corrected]. Neurobiol Dis (1999) 1.54
Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet (1990) 1.51
Maximum-likelihood analysis of human T-cell X chromosome inactivation patterns: normal women versus carriers of X-linked severe combined immunodeficiency. Am J Hum Genet (1992) 1.50
The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes in breast and colon cancer cell lines. Genome Res (1996) 1.46
Miller-Dieker syndrome: lissencephaly and monosomy 17p. J Pediatr (1983) 1.46
Physical fine mapping of the choroideremia locus using Xq21 deletions associated with complex syndromes. Genomics (1989) 1.44
Clinical phenotype in patients with alpha-synuclein Parkinson's disease living in Greece in comparison with patients with sporadic Parkinson's disease. J Neurol Neurosurg Psychiatry (2001) 1.43
Tightly linked flanking markers for the Lowe oculocerebrorenal syndrome, with application to carrier assessment. Am J Hum Genet (1988) 1.40
Association of the NPAS3 gene and five other loci with response to the antipsychotic iloperidone identified in a whole genome association study. Mol Psychiatry (2008) 1.35
Serine phosphorylation, chromosomal localization, and transforming growth factor-beta signal transduction by human bsp-1. J Biol Chem (1996) 1.34
Linkage of Niemann-Pick disease type C to human chromosome 18. Proc Natl Acad Sci U S A (1993) 1.33
The genomic region encompassing the nephropathic cystinosis gene (CTNS): complete sequencing of a 200-kb segment and discovery of a novel gene within the common cystinosis-causing deletion. Genome Res (2000) 1.32
Dinucleotide repeat polymorphisms at the DXS453, DXS454 and DXS458 loci. Nucleic Acids Res (1990) 1.32
Choroideremia and deafness with stapes fixation: a contiguous gene deletion syndrome in Xq21. Am J Hum Genet (1989) 1.29
Identification, localization and characterization of the human gamma-synuclein gene. Hum Genet (1998) 1.27
X-linked severe combined immunodeficiency: localization within the region Xq13.1-q21.1 by linkage and deletion analysis. Am J Hum Genet (1989) 1.26
Mapping X-linked ophthalmic diseases: II. Linkage relationship of X-linked retinitis pigmentosa to X chromosomal short arm markers. Hum Genet (1985) 1.23
Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea. Am J Respir Crit Care Med (2001) 1.22
Mapping the Lowe oculocerebrorenal syndrome to Xq24-q26 by use of restriction fragment length polymorphisms. J Clin Invest (1987) 1.22
Ocrl1, a PtdIns(4,5)P(2) 5-phosphatase, is localized to the trans-Golgi network of fibroblasts and epithelial cells. J Histochem Cytochem (2000) 1.22
Alpha synuclein in neurodegenerative disorders: murderer or accomplice? Nat Med (1998) 1.21
Recombination and amplification of pyrimidine-rich sequences may be responsible for initiation and progression of the Xq27 fragile site: an hypothesis. Am J Med Genet (1986) 1.19
Linkage analysis in X-linked ocular albinism. Genomics (1991) 1.17
Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia. Mol Psychiatry (2008) 1.16
Newborn screening for sickling hemoglobinopathies. Houston, 1976 to 1980. Am J Dis Child (1984) 1.16
Characterization of point mutations in the same arginine codon in three unrelated patients with ornithine transcarbamylase deficiency. J Clin Invest (1988) 1.16
Thymidylate synthase-deficient Chinese hamster cells: a selection system for human chromosome 18 and experimental system for the study of thymidylate synthase regulation and fragile X expression. Am J Hum Genet (1985) 1.15
Physical mapping and genomic structure of the Lowe syndrome gene OCRL1. Hum Genet (1997) 1.15
Predisposition of Wolfram syndrome heterozygotes to psychiatric illness. Mol Psychiatry (1998) 1.14
Spectrum of mutations in the OCRL1 gene in the Lowe oculocerebrorenal syndrome. Am J Hum Genet (1997) 1.14
alpha-synuclein is phosphorylated by members of the Src family of protein-tyrosine kinases. J Biol Chem (2000) 1.13
Genetics of Parkinson's disease. Hum Mol Genet (1997) 1.13
Choroideremia is linked to the restriction fragment length polymorphism DXYS1 at XQ13-21. Am J Hum Genet (1985) 1.12
New mutation and prenatal diagnosis in ornithine transcarbamylase deficiency. Am J Hum Genet (1986) 1.12
Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells. Biochem Biophys Res Commun (1996) 1.11
The Gardner syndrome. Significance of ocular features. Ophthalmology (1984) 1.11
The effect of missense mutations in the RhoGAP-homology domain on ocrl1 function. Mol Genet Metab (2006) 1.11
Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice. Genomics (1998) 1.10
Cellular and viral splicing factors can modify the splicing pattern of CFTR transcripts carrying splicing mutations. Hum Mol Genet (2000) 1.10
Structure and chromosomal localization of the human homeobox gene Prox 1. Genomics (1996) 1.10
Genetic analysis of families with Parkinson disease that carry the Ala53Thr mutation in the gene encoding alpha-synuclein. Am J Hum Genet (1999) 1.10
Mosaicism for an intragenic deletion in a boy with mild ornithine transcarbamylase deficiency. N Engl J Med (1988) 1.09
Chromosomal localization of the genes for the vitronectin and fibronectin receptors alpha subunits and for platelet glycoproteins IIb and IIIa. J Clin Invest (1988) 1.09
Use of comparative physical and sequence mapping to annotate mouse chromosome 16 and human chromosome 21. Genomics (2001) 1.08
Cystic fibrosis in Jews: frequency and mutation distribution. Genet Test (1997) 1.06
Multipoint linkage analysis of loci in the proximal long arm of the human X chromosome: application to mapping the choroideremia locus. Am J Hum Genet (1987) 1.06